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ABSTRACT 
 
Comparison of RT-PCR-Dot Blot Hybridization Based on Radioisotope 32P with 
Conventional RT-PCR and Commericial ELISA Assays for Blood Screening of HIV-1.  
There are many commercial ELISA and rapid test kits that have been used for blood 
screening; however, the kits can give false positive and negative results. Therefore, RT-PCR 
(Reverse Transcription Polymerase Chain Reaction) - Dot Blot Hybridization based on 
radioisotope 32P (RDBR) method was developed in this research, to compare the method with 
the conventional RT-PCR and commercial ELISA Enzyme-Linked Immunosorbent Assay) kit. 
This method is efficient for screening of large blood specimens and surveillance study. Eighty 
seven samples were used and serum of the samples were tested by ELISA to detect HIV-1. 
The HIV-1 RNA genome was extracted from plasma samples and tested using the RT-PCR and 
RDBR methods. Of 87 samples that were tested, the rates of positive testing of the RT-PCR, 
the RDBR, and the ELISA were 71.26%, 74.71%, and 80.46%, respectively. The RDBR (a 
combination of RT-PCR and dot blot hybridization) was more sensitive than conventional RT-
PCR by showing 3.45% in increase number of positive specimens. The results showed that of 
9 samples (10.34%) were negative RDBR and positive ELISA, while 4 samples (4.60%) were 
negative ELISA and positive RDBR. The two methods showed slightly difference in the results 
but further validation is still needed. However, RDBR has high potential as an alternative 
method for screening of blood in large quantities when compared to method of conventional 
RT-PCR and ELISA. 
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ABSTRAK 
 
Perbandingan Uji RT-PCR-Hibridisasi Dot Blot Bertanda Radioisotop 32P, RT-
PCR Konvensional dan ELISA Komersial untuk Skrining Darah Terhadap HIV-1. 
Banyak uji berupa kit komersial seperti ELISA dan uji cepat yang digunakan untuk skrining 
darah ; namun penggunaan kit tersebut dapat memberikan hasil yang salah (false positive atau 
false negative). Oleh karenanya, dalam penelitian ini dikembangkan metode RT-PCR — 
Hibridisasi Dot blot bertanda radioisotop 32P (RDBR) dan kemudian dibandingkan dengan 
metode RT-PCR konvensional dan kit ELISA komersial. Metode ini efisien untuk skrining 
sampel darah dalam jumlah banyak dan untuk salah satu penelitian survei. Dalam penelitian 
ini digunakan 87 sampel darah, dan serum dari sampel diuji untuk mendeteksi HIV-1 dengan 
ELISA. Metode RT-PCR dan RDBR digunakan untuk mendeteksi HIV-1 dari  genom RNA 
HIV-1 yang diektraksi dari plasma darah. Dari 87 sampel yang diuji dengan metode RT-PCR, 
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RDBR dan ELISA menunjukkan persentase hasil positif HIV-1 masing-masing adalah 71,26%; 
74,71%, dan 80,46%. Metode RDBR lebih sensitif dari pada RT-PCR konvensional hal ini 
terlihat dengan bertambahnya jumlah hasil positif sebanyak 3,45%. Data percobaan 
menunjukkan bahwa 9 sampel (10,34%) adalah hasil negatif RDBR dan positif ELISA, 
sedangkan 4 (4,60%) sampel negative ELISA dan positif RDBR. Ke dua metode tersebut 
menunjukkan sedikit perbedaan hasil, namun demikian hasil ini masih memerlukan validasi. 
Metode RDBR memiliki potensi tinggi sebagai suatu metode alternatif  untuk skrining darah 
dalam jumlah banyak jika dibandingkan dengan metode RT-PCR konvensional dan ELISA. 
Kata kunci : HIV-1, radioisotop, hibridisasi dot blot, RT-PCR, ELISA 
 
 
 
 
INTRODUCTION 
 
 Blood transfusion is an important part 
in health care for patients that need blood 
components because of deficiency in 
particular blood components or because of 
too much bleeding. According to WHO, HIV 
is one of blood burden diseases that has to 
be screened [1]. However, HIV-1 infections 
because of HIV contaminated blood 
transfusions still occur for about 5 — 10% 
worldwide [2]. The infections can be caused 
by many factors, such as weak health, rural 
settings, potentially risky donors, 
transfusion, and insufficient HIV-1 screening 
[1, 3]. At emergency situations, blood 
transfusion without screening is performed 
because of limitations in test kit and reagent 
supplies [3]. 
 Enzyme Immunoassay (EIA) and rapid 
tests are recommended to screen HIV-1 in 
sera of blood samples for surveillance and 
diagnostic purpose, due to the fact that both 
tests are the most accurate and cost-effective 
[4]. The EIA and rapid tests contain antigens 
of HIV-1 and they can detect antibodies 
(Abs) to HIV -1. However, screening by the 
tests is not possible if the HIV-1 infected 
persons do not produce HIV-1 specific Abs, 
or have an immunological dysfunction 
caused by the course of aggressive diseases, 
or at the early phase of infection when the 
HIV-1 specific Abs has not been produced 
yet [5, 6]. In such conditions, serological 
diagnosis of HIV-1 infection can yield false 
negative tests so that the HIV-1 transmission 
to naïve individuals could occur. 
 The molecular techniques for HIV-1 
detection have been developed including 
conventional and real time RT-PCR. Both 
assays are often used as routine tests for 
variety number of samples. The 
conventional RT-PCR is not sensitive, while 
the real time RT-PCR is very expensive 
because it needs, special thermal cycle 
machine, and almost all health care services 
in developing countries including Indonesia 
such machine is not available yet. The real 
time RT-PCR reagents are also very 
expensive especially for large samples. For 
these reasons, the assessment by using 
RDBR method and comparison with the 
conventional RT-PCR and commercial 
ELISA kit has tobe carried out. The RDBR is 
not only a highly sensitive method [7] but 
can also probe the DNA targets for 96 
samples in one test; thus, the RDBR is a 
suitable method for screening of larger blood 
samples and for surveillance purpose. 
 
 
MATERIALS AND METHODS 
 
 Clinical Specimen and ELISA Test. 
Eighty-seven of plasma samples were used 
in this study. All samples were tested by 
Vironostika HIV Uniform II Ag/Ab 
(biomerieux). The kit can detect both HIV-1 
antigen and anti HIV-1 Ab simultaneously. 
 Viral RNA Extraction. The HIV-1 
RNA were extracted and purified by 
QIAamp Viral RNA Mini Kit (Qiagen) with 
50 μL of final elution. The eluate containing 
viral RNA was directly used for RT-PCR. 
 RT-PCR. In RT-PCR reaction, forward 
[5’-CAG CAT TAT CAG AAG GAG CCA C-
3’] and reverse [5’-TCT GCA GCT TCC TCA 
TTG ATG G-3’] primers were used (8). The 
Comparison of RT-PCR-Dot Blot Hybridization Based on 
Radioisotope 32P with Conventional RT-PCR and 
Commericial ELISA Assays for Blood Screening of HIV-1 
(Maria Lina R, etc.) 
 
 143
 
ISSN 1907-0322
RT-PCR was performed in 50 μl of reaction 
mixture with the following compositions: 1x 
OneStep RT- PCR buffer, 2.5 mM MgCl2, 1x 
Q solution, 400 μM dNTP mix (dGTP,  
dCTP, dATP, and dTTP), 0.6 μM of each 
primer, 10 U RNAase inhibitor, 2.0 μl  one 
step RT-PCR enzyme mix polymerase 
(Qiagen), and 15 μl extracted viral RNA. The 
RT-PCR was performed with the following 
conditions: 37oC for 30 min; 95oC for 15 
min; 40 cycles of 94oC for 30 sec, 56oC for 
30 sec, and 72oC for 45 sec; 720C for 7 min. 
The PCR products were analyzed on 1.5% 
agarose gel and visualized in ultraviolet 
light. 
 Oligonucleotide and the 
Radioisotope 32P Labeling. An 
oligonucleotide (TDG  GRG GAC AYC ARG 
SAG CHA TRC A) specific for envelope gene 
of HIV-1 was used in this study. The 
oligonucleotide was labeled with 
radioisotope 32P at its 5’ end in 50 μl of 
reaction mixture with the following 
concentrations: 1x kinase buffer, 2 μM 
oligonucleotide probe, 30 μCi of 32P-labeled 
gamma ATP (Perkin-Elmer), 20 U T4 
polynucleotide kinase. The solution then 
was incubated at 37oC for 30 min and and 
finally at 72oC for 10 min. 
 The Radioisotope 32P-Based Dot 
Blot Hybridization. The RDBR was 
performed by the following procedure: 20 μl 
of RT-PCR product that was added with 180 
μl of the dot buffer (0.4 N NaOH and 25 
mM EDTA). The solution was heated at 
1000C and immediately placed on ice. The 
DNA was blotted on membrane by the dot 
blotter (Bio-Rad). The blotted membrane 
was heated at 80oC for 2 h for the fixation of 
the DNA. The membrane was soaked in 
hybridization solution (5x SSPE, 5x 
Denhardt and 0.5 % SDS) at 50oC for 
overnight (16-18 h). Forty milli liter of the 
hybridization solution containing 2 μM of 
the 32P-labeled oligonucleotide probe was 
reacted with membrane at 50oC for 1-2 h. 
The membrane was washed by the washing 
buffer (2x SSPE and 0.1 % SDS) at room 
temperature twice for 30 min each, followed 
by final washing (1x SSPE and 0.1% SDS) at 
50oC for 15 min. The dots that were formed 
on the membrane were detected by 
autoradiography. 
 
 
RESULTS 
 
 In this study, conventional RT-PCR 
positive was defined as a 115-bp DNA 
fragment that is visualized at the right 
position on 1.5% agarose gel (Figure 1). The 
RT-PCR showed specific amplification of 
115 bp 
M       +    1       2       3       4       5      - 
100 
200 
bp 
Figure 1. Analysis of RT-PCR products on 1.5%
agarose gel. 1-5: the five examples for the
RT-PCR positive results showing a 115 bp
DNA bands. M: DNA ladder. -: negative
control. +: positive control. bp: base pair.
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one expected band (Figure 1).  The 
applicability of the RDBR assay to clinical 
specimens was evaluated against 87 plasma 
samples (Figure 2). Of 87 plasma samples, 
the RT-PCR, the RDBR, and the ELISA 
showed that the rates of positive testing for 
HIV-1 are about 71.26%, 74.71%, and 
80.46%, respectively. Three RT-PCR 
negative samples were the RDBR positive; 
thus, the RDBR represents an increase of 
3.45% in number of positive specimens 
(Table 1). None of the RDBR negative 
samples showed RT-PCR positive. Contrast 
results were found while comparing the 
RDBR to the ELISA (Table 1). In this case, 9 
RDBR negative samples were ELISA 
positive, representing an increase of 10.34% 
in number of positive samples by the ELISA, 
and 4 ELISA negative samples were the 
RDBR positive, representing an increase of 
4.60% in number of positive samples by the 
RDBR assay. 
DISCUSSIONS 
 
 In any laboratory, a method to prevent 
the HIV-1 transmission is a crucial need. 
Nowadays, ELISA and rapid tests are the 
first and/or screening assays for diagnosing 
HIV-1. Indeterminate diagnosis test has to 
be confirmed by Western blot. The rapid 
test and ELISA could give false negative and 
positive results [9, 10, 11, 12, 13, 14]. On the 
other hand, Western blot is a sensitive assay 
but it can also give false negative results for 
patients with altered immune responses or 
different disease stages possibly caused by 
HIV-1 infection [5, 6, 15, 16]. Thus, the 
genetic-based HIV-1 diagnosis is the most 
needed method to overcome the limitation 
of serological diagnosis. 
 In this study, the evaluation of the 
RDBR for plasma samples which was 
compared to the method of conventional RT-
PCR and commercial ELISA assays, has 
   1    2    3     4     5    6     7    8     9   10   11   12
A 
B 
C 
Figure 2. Results of the RDBR method. Positive
tests showed the black dots. A2 : positive
control, C10 : negative control. 
A 
No. (%) of specimens 
RDBR+, 
RT-PCR+ 
RDBR+, 
RT-PCR- 
RDBR-, 
RT-PCR+ 
RDBR -, 
RT-PCR- 
Total 
RT-PCR+ 
Total 
DB+ 
HIV-1 62(71.26) 3(3.45) 0(0) 22(25.29) 62(71.26) 65(74.71) 
       
B ELISA+, 
RDBR+ 
ELISA+, 
RDBR- 
ELISA-, 
RDBR+ 
ELISA-, 
RDBR- 
Total 
RDBR+ 
Total 
ELISA+ 
HIV-1 61(70.11) 9(10.34) 4(4.60) 13(14.94) 65(74.71) 70(80.46) 
RDBR: RT-PCR dot blot hybridization based on radioisotope 32P. +: positive. -: negative 
Table 1. Comparison of results between conventional RT-PCR and the RDBR (A), and the
RDBR and ELISA (B) assays 
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been performed. Comparison of the RDBR 
and the conventional RT-PCR showed that 
the RDBR was more sensitive than the 
conventional RT-PCR as can be seen from 
Table 1 in which the number of positive 
samples in the RDBR increases by 3.45%. 
The increase of the number of positive 
samples is caused by the 32P that was 
immobilized on HIV-1 specific 
oligonucleotide. Several beacons can be 
attached on oligonucleotide such as 32P, 
biotin, alkaline phosphatase, and sulphone. 
Among them, the 32P yields the strongest 
signal that make the 32P-based method to be 
the most sensitive [7]. If we consider the 
program in preventing the HIV-1 
transmission, the percentage (3.45%) is very 
significant to hamper the HIV-1 
transmission. Therefore, it is suggested that 
to use not only  conventional RT-PCR assay 
for detection of HIV-1 but also a combined 
RT-PCR and dot-blot hybridization method. 
The combination method was also suggested 
by Lopez-Jimena and colleagues because it 
could increase the detection rate up to 
90.62% [17]. 
 The comparison of the RDBR and the 
ELISA showed conflicting results, because 9 
RDBR negative samples were ELISA positive 
and 4 ELISA negative samples were RDBR 
positive (Table 1). Ly et al. has evaluated 7 
HIV antigen-Ab combination assays, 
including the Vironostika kit, for detection 
of seroconversion, HIV Ab, and HIV antigen 
variants [18]. The result showed that of 50 
HIV Ab positive samples, the Vironostika kit 
could detect only 44 of them. Moreover, 
Iqbal et al. reported only one false positive 
result by the Vironostika [19]. A report of 
the performance evaluation survey for HIV-
1 Ab testing showed that of 964 HIV-1 
positive samples, the Vironostika kit yielded 
only one false positive and 1 negative results 
[20]. A recent report showed that of 73 HIV-
1 positive samples, sensitivity and specificity 
of the Vironostika kit were 100% and 97%, 
respectively [21]. Based on this data, the 
Vironostika kit could yield the false positive 
and negative results. The false negative 
results of ELISA tests could be caused by 
window-period phase and immunological 
dysfunction [5, 6, 15], while the false 
positive results could occur in people with 
acute non HIV-1 infection, recent influenza 
vaccination, autoimmune disorders, renal 
failure, cystic fibrosis, multiple pregnancies, 
liver disease, parenteral substance abuse, 
hemodialysis, and blood transfusions [22-
24]. The researchers recommended using at 
least two or more ELISA kits to improve the 
sensitivity and specificity of assay [18, 19]. 
In this study, we only used one ELISA kit 
(the Vironostika kit); therefore, the ELISA 
results might not represent the actual test 
results. 
 The RDBR method is supposed to be a 
more high sensitive and specific method 
than the ELISA since  the Vironostika kit 
still yields  false positive and negative tests. 
Results of this experiment showed that 9 of 
87 samples (10. 34%) and 4 of 87 samples 
(4.60%) were false positive and negative, 
respectively. Several researchers have 
reported the comparison studies of dot blot 
hybridization with the ELISA methods for 
detection of other microorganisms [25, 26, 
27, 28]. They found that the PCR/RT-PCR-
dot blot hybridization was much more 
sensitive and specific than the ELISA or 
serology assay. Another possible reason is 
that the primers used in this study are not 
able to amplify particular HIV-1 strains 
resulted from the high mutation rate of the 
HIV-1 genome. The assumptions need to be 
confirmed in the future study by using a 
high sensitive counterpart method such as 
real time RT-PCR. 
 
 
CONCLUSIONS 
 
 The RDBR, a combined conventional 
RT-PCR and dot blot hybridization method 
was succesfully developed. It has high  
potential to be used as an alternative assay 
in screening large blood specimens 
particularly for surveillance studies. This 
method was more sensitive than 
conventional RT-PCR by showing the 
increasing number of positive specimens 
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about 3.45%. In comparison with ELISA, the 
RDBR method showed lower sensitivity and 
specificity than ELISA ; however,  the 
results need to be validated in the future 
because of the potentially false results that 
ELISA can produce, as having been reported 
by many researchers. 
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